GPRC5A and lung cancer: Chronic NTHi exposure in Gprc5a-/- mice resulted in increased levels of inflammatory mediators followed by recruitment of inflammatory cells into the lungs (COPD-like inflammation) and lung cancer promotion, similar to what we have previously described in our K-ras induced mouse model [13].